175 related articles for article (PubMed ID: 15810637)
1. Clinical management of hepatic malignancies: ferucarbotran-enhanced magnetic resonance imaging versus contrast-enhanced spiral computed tomography.
Lencioni R; Della Pina C; Bruix J; Majno P; Grazioli L; Morana G; Filippone A; Laghi A; Bartolozzi C
Dig Dis Sci; 2005 Mar; 50(3):533-7. PubMed ID: 15810637
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
3. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
[TBL] [Abstract][Full Text] [Related]
4. Detection of small hypervascular hepatocellular carcinomas in cirrhotic patients: comparison of superparamagnetic iron oxide-enhanced MR imaging with dual-phase spiral CT.
Lee JM; Kim IH; Kwak HS; Youk JH; Han YM; Kim CS
Korean J Radiol; 2003; 4(1):1-8. PubMed ID: 12679628
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging.
Strotzer M; Gmeinwieser J; Schmidt J; Fellner C; Seitz J; Albrich H; Zirngibl H; Feuerbach S
Acta Radiol; 1997 Nov; 38(6):986-92. PubMed ID: 9394654
[TBL] [Abstract][Full Text] [Related]
6. Ferucarbotran-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Choi D; Kim SH; Lim JH; Lee WJ; Kim MJ; Lim HK; Lee SJ
AJR Am J Roentgenol; 2005 Apr; 184(4):1069-76. PubMed ID: 15788575
[TBL] [Abstract][Full Text] [Related]
7. Ferucarbotran-enhanced 3.0-T magnetic resonance imaging using parallel imaging technique compared with triple-phase multidetector row computed tomography for the preoperative detection of hepatocellular carcinoma.
Kim SJ; Kim SH; Lee J; Chang S; Kim YS; Kim SH; Jeon YH; Choi D
J Comput Assist Tomogr; 2008; 32(3):379-85. PubMed ID: 18520541
[TBL] [Abstract][Full Text] [Related]
8. Focal liver lesions: detection and characterization at double-contrast liver MR Imaging with ferucarbotran and gadobutrol versus single-contrast liver MR imaging.
Heilmaier C; Lutz AM; Bolog N; Weishaupt D; Seifert B; Willmann JK
Radiology; 2009 Dec; 253(3):724-33. PubMed ID: 19789232
[TBL] [Abstract][Full Text] [Related]
9. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography.
Lencioni R; Donati F; Cioni D; Paolicchi A; Cicorelli A; Bartolozzi C
MAGMA; 1998 Dec; 7(2):76-87. PubMed ID: 9951768
[TBL] [Abstract][Full Text] [Related]
10. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.
Reimer P; Jähnke N; Fiebich M; Schima W; Deckers F; Marx C; Holzknecht N; Saini S
Radiology; 2000 Oct; 217(1):152-8. PubMed ID: 11012438
[TBL] [Abstract][Full Text] [Related]
11. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US.
Vogl TJ; Schwarz W; Blume S; Pietsch M; Shamsi K; Franz M; Lobeck H; Balzer T; del Tredici K; Neuhaus P; Felix R; Hammerstingl RM
Eur Radiol; 2003 Feb; 13(2):262-72. PubMed ID: 12598989
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
13. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver.
Müller RD; Vogel K; Neumann K; Hirche H; Barkhausen J; Stöblen F; Henrich H; Langer R
Acta Radiol; 1999 Nov; 40(6):628-35. PubMed ID: 10598852
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography.
Kim YK; Kwak HS; Han YM; Kim CS
J Comput Assist Tomogr; 2007; 31(5):702-11. PubMed ID: 17895780
[TBL] [Abstract][Full Text] [Related]
15. Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT.
Kang BK; Lim JH; Kim SH; Choi D; Lim HK; Lee WJ; Lee SJ
Radiology; 2003 Jan; 226(1):79-85. PubMed ID: 12511672
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT.
Kim YK; Kwak HS; Kim CS; Chung GH; Han YM; Lee JM
Radiology; 2006 Feb; 238(2):531-41. PubMed ID: 16371577
[TBL] [Abstract][Full Text] [Related]
17. The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria.
Leoni S; Piscaglia F; Golfieri R; Camaggi V; Vidili G; Pini P; Bolondi L
Am J Gastroenterol; 2010 Mar; 105(3):599-609. PubMed ID: 19935786
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
[TBL] [Abstract][Full Text] [Related]
19. Multidetector helical CT plus superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions in cirrhotic liver: a comparison with multi-phase CT during hepatic arteriography.
Yukisawa S; Okugawa H; Masuya Y; Okabe S; Fukuda H; Yoshikawa M; Ebara M; Saisho H
Eur J Radiol; 2007 Feb; 61(2):279-89. PubMed ID: 17070663
[TBL] [Abstract][Full Text] [Related]
20. Tumor-liver contrast and subjective tumor conspicuity of respiratory-triggered T2-weighted fast spin-echo sequence compared with T2*-weighted gradient recalled-echo sequence for ferucarbotran-enhanced magnetic resonance imaging of hepatic malignant tumors.
Ishiyama K; Hashimoto M; Izumi J; Watarai J; Shibata S; Sato T; Yamamoto Y
J Magn Reson Imaging; 2008 Jun; 27(6):1322-6. PubMed ID: 18504744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
